Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies

Polycystic ovary syndrome (PCOS) is marked in 30 to 40% by insulin resistance and hyperandrogenism. Myo-inositol (MI) increases insulin sensitivity, decreases hyperandrogenism and improves the menstrual cycle. Its effect during assisted reproductive technologies (ART) has been studied by many author...

Descripción completa

Detalles Bibliográficos
Autores principales: Merviel, Philippe, James, Pandora, Bouée, Sarah, Le Guillou, Mathilde, Rince, Camille, Nachtergaele, Charlotte, Kerlan, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816413/
https://www.ncbi.nlm.nih.gov/pubmed/33468143
http://dx.doi.org/10.1186/s12978-021-01073-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816413/
https://www.ncbi.nlm.nih.gov/pubmed/33468143
http://dx.doi.org/10.1186/s12978-021-01073-3

Ejemplares similares